Your session is about to expire
← Back to Search
FAZA PET/MRI scan for Critical Limb Ischemia
N/A
Waitlist Available
Led By Patrick Veit-Haibach, MD
Research Sponsored by University Health Network, Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up faza pet/mri 2-3 weeks before endovascular treatment and 4-6 weeks after endovascular treatment
Awards & highlights
Study Summary
This trial will test a new imaging technique, 18F-Fluoroazomycin Arabinoside (FAZA) PET/MR, to see if it can provide more accurate diagnostic information for patients with peripheral artery disease and critical limb ischemia.
Eligible Conditions
- Critical Limb Ischemia
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ faza pet/mri 2-3 weeks before endovascular treatment and 4-6 weeks after endovascular treatment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~faza pet/mri 2-3 weeks before endovascular treatment and 4-6 weeks after endovascular treatment
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Validation of FAZA PET/MRI as a biomarker of hypoxia
Trial Design
1Treatment groups
Experimental Treatment
Group I: FAZA PET/MRI scanExperimental Treatment1 Intervention
PET/MRI scan using radiotracer 18F-Fluoroazomycin Arabinoside
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
FAZA PET/MRI scan
2018
N/A
~40
Find a Location
Who is running the clinical trial?
University Health Network, TorontoLead Sponsor
1,468 Previous Clinical Trials
484,479 Total Patients Enrolled
Patrick Veit-Haibach, MDPrincipal InvestigatorUniversity Health Network, Toronto
7 Previous Clinical Trials
366 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger